Funding Received
$5.5 Million in 1 Round from 2 Investors
Most Recent Funding
$5.5 Million Series A on May 16, 2012
Headquarters:
Erkrath
Description:
Algiax Pharmaceuticals develops products for nervous system disease or dysfunction with a strong focus on neuropathic pain.
Categories:
Biotechnology
Website:
http://www.algiax.com

Company Details

Update
Employees:
2 in CrunchBase

Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro’s in Series A financing from a consortium of private and state-backed investors.

Funding Rounds (1) - $5.5M

Update

Investors (2)

Update
  • 6f4ef4826a9e049e06ab2facd0d69c93

    KFW

    KfW Bankengruppe gives impetus to economic, social and ecological development worldwide. As a...
  • 2c2b624e7df88771174f98e15d4c4370

    High-Tech Gruenderfonds

    German venture capital firm

Offices/Locations (1)

Update
  • Office

    Max-Planck-Str. 15a

    Erkrath, 40699

    DEU